Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives

Huntington’s disease (HD) is an autosomal dominant progressive brain disorder, caused by a pathological expansion of a CAG repeat that encodes the huntingtin gene. This genetic neurodegenerative rare disease is characterized by cognitive, motor, and neuropsychiatric manifestations. The aim of the tr...

Descripción completa

Detalles Bibliográficos
Autores principales: García-González, Xandra, Cubo, Esther, Simón-Vicente, Lucía, Mariscal, Natividad, Alcaraz, Raquel, Aguado, Laura, Rivadeneyra-Posadas, Jéssica, Sanz-Solas, Antonio, Saiz-Rodríguez, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056055/
https://www.ncbi.nlm.nih.gov/pubmed/36983567
http://dx.doi.org/10.3390/jpm13030385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056055/
https://www.ncbi.nlm.nih.gov/pubmed/36983567
http://dx.doi.org/10.3390/jpm13030385

Ejemplares similares